Periductal infiltrating type of intrahepatic cholangiocarcinoma: A rare macroscopic type without any apparent mass

Surgery Today

Volumn 42, Issue 12, 2012, Pages 1189-1194

  Uno, Masanori ^a   Shimada, Kazuaki ^a   Yamamoto, Yusuke ^a   Nara, Satoshi ^a   Esaki, Minoru ^a   Sakamoto, Yoshihiro ^a   Kosuge, Tomoo ^a   Ojima, Hidenori ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Macroscopic classification; Mass forming plus periductal infiltrating type; Periductal infiltrating type

Indexed keywords

CA 19-9 ANTIGEN; HEPATITIS C ANTIBODY;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT ADENOCARCINOMA; BILE DUCT CARCINOMA; BILE DUCT DILATATION; BILIARY TRACT SURGERY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER INFILTRATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MASS FORMING TYPE BILE DUCT CARCINOMA; MICROSCOPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIDUCTAL INFILTRATING TYPE BILE DUCT CARCINOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; LIVER TUMOR; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84877293739     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0145-5     Document Type: Article

References (21)

1. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676-91.
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353-7.
3. Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma. Histologic classification and modes of spreading. Hum Pathol. 1988;19:1228-34.
4. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol. 1998;69:162-7.
5. Yamamoto J, Kosuge T, Takayama T, Shimada K, Makuuchi M, Yoshida J, et al. Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery. 1992;111:617-22.
6. Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T, et al. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol. 2008;15:590-9.
7. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10:288-91.
8. Liver Cancer Study Group of Japan General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 2nd edn. Tokyo: Kanehara; 2003.
9. Couinaud C. Lobes et segments hepatiques [in French]. Presse Med. 1954;62:709-12.
10. Hirohashi K, Uenishi T, Kubo S, Yamamotu T, Tanaka H, Shuto T, et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology. 2002;49:326-9.
11. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525-31.
12. Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T, et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10:432-40.
13. Yeh CN, Jan YY, Yeh TS, Hwang TL, Chen MF. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol. 2004;11:606-11.
14. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg. 2007;31:2016-22.
15. Yamamoto Y, Shiamda K, Sakamoot Y, Esaki M, Nara S, Ban D. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth. J Surg Oncol. 2009;99:161-5.
16. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009;33:1247-54.
17. Sasaki A, Aramaki M, Kawano K, Mori Y, Nakashima K, Yoshida T, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998;85:1206-9.
18. Ercolani G, Vetrone G, Grazi GL, et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg. 2010;252:107-14.
19. Murakami Y, Uemura K, Sudo T, et al. Prognostic factors after surgical resection for intrahepatic, hilar and distal cholangiocarcinoma. Ann Surg Oncol. 2011;3:651-8.
20. Yamamoto M, Ariizumi S. Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today. 2011;41:896-902.
21. Ohashi K, Nakajima Y, Kanehiro H, Tsutsumi M, Taki J, Aomatsu Y, et al. Ki-ras mutation and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. Gastroenterology. 1995;109:1612-7.